Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) EPS (Basic): 2009-2024

Historic EPS (Basic) for Ironwood Pharmaceuticals (IRWD) over the last 16 years, with Dec 2024 value amounting to $0.01.

  • Ironwood Pharmaceuticals' EPS (Basic) rose 1150.00% to $0.25 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.18, marking a year-over-year increase of 700.00%. This contributed to the annual value of $0.01 for FY2024, which is 100.16% up from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its EPS (Basic) stood at $0.01 for FY2024, which was up 100.16% from -$6.45 recorded in FY2023.
  • Ironwood Pharmaceuticals' EPS (Basic)'s 5-year high stood at $3.26 during FY2021, with a 5-year trough of -$6.45 in FY2023.
  • Moreover, its 3-year median value for EPS (Basic) was $0.01 (2024), whereas its average is -$1.77.
  • In the last 5 years, Ironwood Pharmaceuticals' EPS (Basic) skyrocketed by 386.57% in 2021 and then plummeted by 670.80% in 2023.
  • Yearly analysis of 5 years shows Ironwood Pharmaceuticals' EPS (Basic) stood at $0.67 in 2020, then spiked by 386.57% to $3.26 in 2021, then plummeted by 65.34% to $1.13 in 2022, then tumbled by 670.80% to -$6.45 in 2023, then skyrocketed by 100.16% to $0.01 in 2024.